SAR407899 Single-dose in Treatment of Mild to Moderate Erectile Dysfunction
Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
The primary objective of this clinical trial is to study the ability of SAR407899 to increase
the duration of penile erection in male patients with mild-moderate Erectile Dysfunction.
The secondary objectives of this clinical trial are to study the ability of SAR407899 to
shorten increase the time to erection duration of penile erection in male patients with
mild-moderate Erectile Dysfunction and to determine the overall safety and tolerability of
SAR407899 in these patients.